CRTC1 and neoplasm: In 60-80% of cases, this tumor is associated with a specific genetic fusion CRTC1 or CRCT3::MAML2 [8], which provides a molecular signature for diagnosis, but also has prognostic value, as MAML2-positive tumors are associated with a much better survival rate [13].